Unknown

Dataset Information

Retreatment of Chronic Hepatitis C Infection with Telaprevir: Preliminary Results in Turkey.


ABSTRACT:

Background

The use of pegylated interferon alpha and ribavirin (PegIFN/RBV) for the retreatment of chronic hepatitis C virus (HCV) infection without a sustained virological response (SVR) prior to PegIFN/RBV treatment has resulted in low success rates.

Aims

To investigate the efficacy and safety of telaprevir (TVR) in combination with PegIFN/RBV in patients infected with HCV genotypes 1 and 4 who were previously treated with PegIFN/RBV and failed to achieve SVR.

Study design

Multi-center, retrospective, cross-sectional study.

Methods

The study included 111 patients: 80 prior relapsers, 25 prior null responders, and six prior partial responders to PegIFN/RBV treatment. The patients were given TVR/PegIFN/RBV for 12 weeks, followed by a 12-week PegIFN/RBV treatmen

SUBMITTER: Aygen B 

PROVIDER: S-EPMC4497692 | biostudies-literature | 2015 Jul

REPOSITORIES: biostudies-literature